Lymphoadenopathy during Lyme Borreliosis Is Caused by Spirochete Migration-Induced Specific B Cell Activation

English version České info

Lymphadenopathy is a hallmark of acute infection with Borrelia burgdorferi, a tick-borne spirochete and causative agent of Lyme borreliosis, but the underlying causes and the functional consequences of this lymph node enlargement have not been revealed. The present study demonstrates that extracellular, live spirochetes accumulate in the cortical areas of lymph nodes following infection of mice with either host-adapted, or tick-borne B. burgdorferi and that they, but not inactivated spirochetes, drive the lymphadenopathy. The ensuing lymph node response is characterized by strong, rapid extrafollicular B cell proliferation and differentiation to plasma cells, as assessed by immunohistochemistry, flow cytometry and ELISPOT analysis, while germinal center reactions were not consistently observed. The extrafollicular nature of this B cell response and its strongly IgM-skewed isotype profile bear the hallmarks of a T-independent response. The induced B cell response does appear, however, to be largely antigen-specific. Use of a cocktail of recombinant, in vivo-expressed B. burgdorferi-antigens revealed the robust induction of borrelia-specific antibody-secreting cells by ELISPOT. Furthermore, nearly a quarter of hybridomas generated from regional lymph nodes during acute infection showed reactivity against a small number of recombinant Borrelia-antigens. Finally, neither the quality nor the magnitude of the B cell responses was altered in mice lacking the Toll-like receptor adaptor molecule MyD88. Together, these findings suggest a novel evasion strategy for B. burgdorferi: subversion of the quality of a strongly induced, potentially protective borrelia-specific antibody response via B. burdorferi's accumulation in lymph nodes.

Vyšlo v časopise: Lymphoadenopathy during Lyme Borreliosis Is Caused by Spirochete Migration-Induced Specific B Cell Activation. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1002066
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002066

Souhrn

Zdroje

1. BaconRMKugelerKJMeadPS 2008 Surveillance for Lyme disease - United States, 1992–2006. MMWR Surveill Summ 57 1 9

2. RandolphSE 2001 The shifting landscap of tick-borne zoonoses: tick-borne encephalitiis and Lyme borreliosis in Europe. Phil Trans R Soc Lond 356 1045 1056

3. SteereACSchoenRTTaylorE 1987 The clinical evolution of Lyme arthritis. Ann Intern Med 107 725 731

4. SteereAC 1989 Lyme disease. N Engl J Med 321 586 596

5. SteereAC 2001 Lyme disease. N Eng J Med 345 115 125

6. SummersBAStraubingerAFJacobsonRHChangYFAppelMJG 2005 Histopathological studies of experimental Lyme disease in dogs. J Comp Path 133 1 13

7. DurayPHSteereAC 1988 Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci 539 65 79

8. SteereACBartenhagenNHCraftJEHutchinsonGJNewmanJH 1983 The early clinical manifestations of Lyme disease. Ann Intern Med 99 76 82

9. deSouzaMSFikrigESmithALFlavellRABartholdSW 1992 Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis 165 471 478

10. HonarvarNSchaibleUEGalanosCWallichRSimonMM 1994 A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencey. Immunol 82 389 396

11. MaYWeisJJ 1993 Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 61 3843 3853

12. SchoenfeldRAraneoBMaYYangLWeisJJ 1992 Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun 60 455 464

13. SigalLHSteereACDwyerJM 1988 In vivo and in vitro evidence of B cell hyperactivity during Lyme disease. J Rheumatol 15 648 654

14. TaiKFMaYWeisJJ 1994 Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun 62 520 528

15. WhitmireWMGaronCF 1993 Specific and nonspecific responses of murine B-cells to membrane blebs of Borrelia burgdorferi. Infect Immun 61 1460 1467

16. YangLMMaYSchoenfeldRGriffithsMEichwaldE 1992 Evidence for lymphocyte-B mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun 60 3033 3041

17. St JohnALAbrahamSN 2009 Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med 15 1259 1265

18. JawdatDMRowdenGMarshallJS 2006 Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 177 1755 1762

19. McLachlanJBHartJPPizzoSVShelburneCPStaatsHF 2003 Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4 1199 1205

20. Aguero-RosenfeldMENowakowskiJMcKennaDFCarbonaroCAWormserGP 1993 Serodiagnosis in early Lyme disease. J Clin Microbiol 31 3090 3095

21. AgueroRosenfeldMENowakowskiJBittkerSCooperDNadelmanRB 1996 Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34 1 9

22. DresslerFWhalenJAReinhardtBNSteereAC 1993 Western blotting in the serodiagnosis of early Lyme disease. J Infect Dis 167 392 400

23. KalishRAMcHughGGranquistJSheaBRuthazerR 2001 Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active disease. Clin Infect Dis 33 780 785

24. SteereACCoburnJGlicksteinL 2004 The emergence of Lyme disease. J Clin Invest 113 1093 1101

25. BartholdSWLevySAFikrigEBockenstedtLKSmithAL 1995 Serologic response of naturally exposed or vaccinated dogs to Borrelia burgdorferi, the agent of Lyme borreliosis. J Am Vet Med Assoc 207 1435 1440

26. BartholdSWFengSBockenstedtLKFikrigEFeenK 1997 Protective and arthritis-resolving activity in serum from mice infected with Borrelia burgdorferi. Clin Infect Dis 25 S9 S17

27. BartholdSWFikrigEBockenstedtLKPersingDH 1995 Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun 63 2255 2261

28. FikrigEBockenstedtLKBartholdSWChenMTaoH 1994 Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis 169 568 574

29. McKisicMDBartholdSW 2000 T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect Immun 68 5190 5197

30. BartholdSWBockenstedtLK 1993 Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61 4696 4702

31. AdachiOKawaiTTakedaKMatsumotoMTsutsuiH 1998 Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 143 150

32. HodzicETunevSFengSFreetKBartholdS 2005 Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo. Infect Immun 73 3313 3321

33. BarbourAG 1984 Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57 521 525

34. HodzicEFengSFreetKJBorjessonDLBartholdSW 2002 Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect Immun 70 3382 3388

35. RothaeuslerKBaumgarthN 2006 Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry. Cytometry A 69 249 259

36. FengSHodzicEStevensonBBartholdSW 1998 Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun 66 2827 2835

37. RauFCDieterJLuoZPriestSOBaumgarthN 2009 B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion. J Immunol 183 7661 7671

38. BartholdSWBeckDSHansenGMTerwilligerGAMoodyKD 1990 Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162 133 138

39. deSilvaAMFikrigE 1997 Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest 99 377 379

40. FikrigEBartholdSWChenMGrewalISCraftJ 1996 Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol 157 1 3

41. BartholdSWHodzicETunevSFengS 2006 Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect Immun 74 4817 4825

42. LiuNMontgomeryRRBartholdSWBockenstedtLK 2004 Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72 3195 3203

43. MacLennanICToellnerKMCunninghamAFSerreKSzeDM 2003 Extrafollicular antibody responses. Immunol Rev 194 8 18

44. GoodnowCCVinuesaCGRandallKLMackayFBrinkR 2010 Control systems and decision making for antibody production. Nat Immunol 11 681 688

45. BockenstedtLKKangIShanafeltM-CKumarHCampbellM 1997 Lyme borreliosis in B cell- and ab T cell-deficient mice: distinct roles for specific immunity in disease regression. Clin Infect Dis 25

46. CrotherTRChampionCIWuXYBlancoDRMillerJN 2003 Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun 71 3419 3428

47. FengSHodzicEFreetKBartholdSW 2003 Immunogenicity of Borrelia burgdorferi arthritis-related protein. Infect Immun 71 7211 7214

48. LiangFTYanJMbowMLSviatSLGilmoreRD 2004 Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 72 5759 5767

49. SchwanTGPiesmanJ 2000 Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38 382 388

50. SukKDasSSunWJwangBBartholdSW 1995 Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci USA 92 4269 4273

51. CassattDRPatelNKUlbrandtNDHansonMS 1998 DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochemia and is a target for protective antibodies. Infect Immun 66 5379 5387

52. LiangFTJacobsMBBowersLCPhilippMT 2002 An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 195 415 422

53. SimpsonWJCieplakWSchrumpfMEBarbourAGSchwanTG 1994 Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. F E M S Microbiol Lett 119 381 388

54. FengSHodzicEBartholdSW 2000 Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect Immun 68 4169 4173

55. HansonMSCassattDRGuoBPPatelNKMcCarthyMP 1998 Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect Immun 66 2143 2153

56. PalUWangPBaoFYangXSamantaS 2008 Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med 205 133 141

57. ProbertWSLeFebvreRB 1994 Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Infect Immun 62 1920 1926

58. BartholdSWdeSouzaMFengS 1996 Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 74 57 67

59. CabelloFCGodfreyHPNewmanSA 2007 Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol 15 350 354

60. BelperronAADaileyCMBoothCJBockenstedtLK 2007 Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection. Infect Immun 75 3354 3360

61. de SouzaMSSmithALBeckDSKimLJHansenGMJr 1993 Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation. Infect Immun 61 4493 4497

62. PachnerARDelaneyERicaltonNS 1993 Murine Lyme borreliosis: route of inoculation determines immune response and infectivity. Regional Immunol 4 345 351